Atlas Trials

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

Clinical trial NCT04590586 · COMPLETED

Trial details

NCT number
NCT04590586
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-11-24
Primary completion
2021-08-03
Enrollment
515

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.